Ernesto Moreno - Concepedia

Author

Ernesto Moreno

Center of Molecular Immunology (Cuba)ORCID

Also Known As

E MORENO, E Moreno, E. MORENO, E. Moreno, ERNESTO MORENO, Eduardo de Jesús Mendoza Moreno, Ernesto Moreno, Mario E Valdés-Tresanco, Mario E. Valdés-Tresanco, Mario S. Valdés-Tresanco

Publications

4.6K

Citations

H-Index

107

Concepts

All Affiliations

Center of Molecular Immunology (Cuba)Universidad de Medellín University of Gothenburg Centro de Ingeniería Genética y Biotecnología University of Oslo

About

Ernesto Moreno is an author at Center of Molecular Immunology (Cuba) specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	18	919
2	Engineering	6	6	121
3	Natural Sciences	3	3	68
4	Health Sciences	2	2	28
5	Public Health	2	2	35

Ernesto Moreno

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
gmx_MMPBSA: A New Tool to Perform End-State Free Energy Calculations with GROMACS Mario S. Valdés‐Tresanco, Mario E. Valdés‐Tresanco, Pedro A. Valiente, Journal of Chemical Theory and Computation	2021	2.6K
AMDock: a versatile graphical tool for assisting molecular docking with Autodock Vina and Autodock4 Mario S. Valdés‐Tresanco, Mario E. Valdés‐Tresanco, Pedro A. Valiente, Biology Direct	2020	336
Nimotuzumab, an Antitumor Antibody that Targets the Epidermal Growth Factor Receptor, Blocks Ligand Binding while Permitting the Active Receptor Conformation Ariel Talavera, Rosmarie Friemann, Silvia Gómez-Puerta, Cancer Research Crystal StructureEpidermal Growth FactorImmunologyImmunotherapyActive Receptor Conformation	2009	193
Humanization of a mouse monoclonal antibody that blocks the epidermal growth factor receptor: recovery of antagonistic activity Ernesto Moreno, Kathryn Amour, J Lombardero, Immunotechnology Mouse Monoclonal AntibodyAntagonistic ActivityImmunocytochemical TechniqueAutoimmune DiseaseImmunology	1997	192
Human IL-2 Mutein with Higher Antitumor Efficacy Than Wild Type IL-2 Tania Carmenate, Anabel Pacios-Michelena, Michel Enamorado, The Journal of Immunology T-regulatory CellImmunologyImmune RegulationImmunoeditingImmunotherapeutics	2013	126
Blocking IL-2 Signal In Vivo with an IL-2 Antagonist Reduces Tumor Growth through the Control of Regulatory T Cells Tania Carmenate, Yaquelin Ortiz-Miranda, Michel Enamorado, The Journal of Immunology	2018	54
A view on EGFR-targeted therapies from the oncogene-addiction perspective Rolando Pérez, Tania Crombet, Joel de León, Frontiers in Pharmacology Tumor Cell GrowthOncologyNovel TherapyOncogenic AgentAddiction	2013	46
Structure and Molecular Interactions of a Unique Antitumor Antibody Specific for N-Glycolyl GM3 Ute Krengel, Lise‐Lotte Olsson, Carlos Martínez, Journal of Biological Chemistry	2004	42
EGFR-Targeting as a Biological Therapy: Understanding Nimotuzumab’s Clinical Effects Rolando Pérez, Ernesto Moreno, Greta Garrido, Cancers ImmunologyBiological TherapyDermatologyImmunotherapyTumor Biology	2011	42
Enzymatic changes in pectic polysaccharides related to the beneficial effect of soaking on bean cooking time Enrique Martínez-Manrique, Carmen Jacinto‐Hernández, Ramón Garza-García, Journal of the Science of Food and Agriculture	2011	41

Page 1